[Determination of tumor marker CA 125 in the cancer of the ovary: comparison of immunoenzyme and immunoradiometry methods].
CA 125, tumor marker newly appeared, is used in ovarian carcinomas. Its determination in serum is an important progress, not only in diagnosis but above all at the time of monitoring of clinical course during the treatment. The determination is possible with immunoradiometric assay (IRA) or enzyme immunoassay (EIA). The comparative study show a good correlation between these two methods. Both give comparable results. The choice for either method depends on equipment of laboratory.
Fasquelle
D
D
Laboratoire SR de Biologie, Centre Hospitalier Général, BRIANCON, France.
Villemain
D
D
Meffre
G
G
Agnius-Delord
C
C
D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood*; D011863:Radioimmunoassay
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor
Dosage du marqueur tumoral CA 125 dans les cancers de l'ovaire: comparaison des méthodes immunoenzymatique et immunoradiométrique.